Navigation Links
Radiologists encouraged to look beyond cancer for clinically unseen diseases
Date:8/14/2007

Radiologists can diagnose venous thromboembolic disease (VTED) in cancer patients earlier by looking more carefully at CT scans of the thorax, abdomen, and pelvis which are regularly done to determine the extent or stage of the cancer, according to a recent study conducted by radiologists at the University College Hospital in Galway, Ireland.

Venous thromboembolic disease can be fatal if left untreated. The study focused on pulmonary embolism (PE), inferior vena cava (IVC), and iliac and iliofemoral deep venous thromboses (DVTs) in oncology patients.

Wed noticed a number of clinically unsuspected deep venous thrombosis and pulmonary emboli on staging CT thorax, abdomen and pelvis examinations which goes unnoticed, said Carmel Cronin, MD, lead author of the study. When we do a CT to stage the cancer we can see both the pulmonary arterial system and the pelvic and lower extremity venous system, she said.

The study included 736 patients ranging from 20 to 79 years of age. According to the study, 23 patients had unsuspected iliofemoral DVT and four had common iliac vein involvement. The study also showed that 13 patients had an unsuspected pulmonary embolism.

We were surprised by the results, said Dr. Cronin. However, as outlined in other literature, the true prevalence of venous thromboembolic disease is underestimated as many are clinically unapparent. Venous thrombosis is estimated to be diagnosed in less than 40% of those with a concomitant venous thrombosis and malignancy, she said.


'/>"/>

Contact: Necoya Lightsey
necoya@arrs.org
703-858-4304
American Roentgen Ray Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Radiologists Find New CT Scans Useful
2. Technology-enabled diagnosis by overseas radiologists
3. Computer Software Less Reliable Than Radiologists Eyes in Detecting Cancerous Tumors
4. Smokers Encouraged To Give Up The Habit
5. Fake Sun Tans Encouraged
6. Doctors Encouraged to Say, “I’m Sorry,” to Patients inUS
7. Seniors Encouraged To Make Use Of Medicare’s Freebie
8. Life Beyond Cancer - Delhi Woman Tells How
9. Intel Outside: Exploring Life beyond the Chip
10. Latest Drug for AMD, Beyond The Reach Of Common Man
11. Medical Course in Kerala is Beyond the Reach of NRIs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... , ... Are You Concerned About Mold In Your Home or Workplace? ... Companies in VA, MD and DC, recently completed its application for the new District ... in the district of Columbia is a good thing stated John Taylor, Owner of ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and Sara ... speak at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference ... Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & ...
(Date:12/2/2016)... Los Angeles, CA (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, ... a lien basis to help personal injury victims find high quality medical care. When ... the Los Angeles area. Fast forward to present day and the now ten-page directory ...
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, ... of its 60-day free trial program for all of the company’s desktop riser ... a truly hassle free experience. , FlexiSpot’s unique desktop risers use an advanced ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, 2016 , ... ... Through an exclusive interview with Mediaplanet, Dr. Murthy explains how he was inspired to ... “Early on I learned that medicine is about more than making diagnoses and prescribing ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Seno Medical Instruments, Inc., the company pioneering the development ... the process of diagnosing breast cancer, today announced that ... surveillance and clinical follow-up study at the 2016 ... from December 6-10, 2016 at the Henry B. Gonzalez ... . Seno Medical Instruments will present two ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. ... months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) ... a significantly better safety and tolerability profile of ropeginterferon alfa-2b ... from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV to ... PharmaEssentia intends to present this data to the FDA ...
(Date:12/4/2016)... 3, 2016 Sickle cell disease (SCD) is ... blood cells that get stuck in veins and block ... failure, and complications leading to death. Each year, approximately ... and most of them lack access to comprehensive care ... long-term therapy for SCD, a pill called hydroxyurea approved ...
Breaking Medicine Technology: